IL153687A0 - Composition and method for enhancing elasticity of tissue - Google Patents
Composition and method for enhancing elasticity of tissueInfo
- Publication number
- IL153687A0 IL153687A0 IL15368701A IL15368701A IL153687A0 IL 153687 A0 IL153687 A0 IL 153687A0 IL 15368701 A IL15368701 A IL 15368701A IL 15368701 A IL15368701 A IL 15368701A IL 153687 A0 IL153687 A0 IL 153687A0
- Authority
- IL
- Israel
- Prior art keywords
- tissue
- composition
- enhancing elasticity
- enhancing
- elasticity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cosmetics (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/584,001 US6506731B1 (en) | 1998-03-13 | 2000-05-30 | Elastin peptide analogs and methods of using same |
US09/580,893 US6794362B1 (en) | 2000-05-30 | 2000-05-30 | Asparagine containing elastin peptide analogs |
US09/580,110 US6809075B1 (en) | 2000-05-30 | 2000-05-30 | Elastin peptide analogs and uses of same incombination with skin enhancing agents |
US09/580,156 US6962904B1 (en) | 1998-03-13 | 2000-05-30 | Elastin peptide analogs and uses thereof |
PCT/US2001/017384 WO2001091700A2 (en) | 2000-05-30 | 2001-05-30 | Composition and method for enhancing elasticity of tissue |
Publications (1)
Publication Number | Publication Date |
---|---|
IL153687A0 true IL153687A0 (en) | 2003-07-06 |
Family
ID=27504943
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15368701A IL153687A0 (en) | 2000-05-30 | 2001-05-30 | Composition and method for enhancing elasticity of tissue |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1392346A4 (no) |
AU (2) | AU2001275018B2 (no) |
CA (1) | CA2415225A1 (no) |
IL (1) | IL153687A0 (no) |
NO (1) | NO20030454L (no) |
NZ (1) | NZ523403A (no) |
WO (1) | WO2001091700A2 (no) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2827170B1 (fr) * | 2001-07-13 | 2004-07-16 | Soc Extraction Principes Actif | Utilisation de peptides pour augmenter l'adhesion cellulaire |
WO2003030860A1 (en) * | 2001-10-05 | 2003-04-17 | Procyte Corporation | Skin care compositions containing peptide copper complexes and retinol, retinol derivatives, or a mixture thereof |
KR20050033510A (ko) * | 2001-10-05 | 2005-04-12 | 프로사이트 코포레이션 | 피부의 색소 과다 침착의 치료방법 |
US20040138103A1 (en) * | 2002-11-07 | 2004-07-15 | Procyte Corporation | Compositions containing peptide copper complexes and metalloproteinase inhibitors and methods related thereto |
DE10260928A1 (de) * | 2002-12-20 | 2004-07-08 | Henkel Kgaa | Verfahren zur Bestimmung von Markern humaner Gesichtshaut |
US6927205B2 (en) | 2003-04-28 | 2005-08-09 | Procyte Corporation | Compositions and methods for treatment of psoriasis |
FR2854897B1 (fr) * | 2003-05-12 | 2007-05-04 | Sederma Sa | Compositions cosmetiques ou dermopharmaceutiques pour reduire les signes du vieillissement cutane. |
EP1765280A1 (en) * | 2004-06-28 | 2007-03-28 | Procyte Corporation | Methods and compositions for preventing and treating hyperpigmentation of skin |
CA2652388A1 (en) | 2006-05-15 | 2007-11-22 | Valio Ltd | New use of therapeutically useful peptides |
WO2008100789A2 (en) | 2007-02-16 | 2008-08-21 | Benaroya Research Institute At Virginia Mason | Compositions and methods for altering elastogenesis |
CN103458911B (zh) | 2011-02-11 | 2016-02-24 | 密歇根大学董事会 | 肽组合物和用于治疗患者的方法 |
MX2013010977A (es) | 2011-03-31 | 2013-10-30 | Procter & Gamble | Sistema, modelos y metodos para identificar y evaluar agentes dermoactivos eficaces para tratar la caspa/dermatitis seborreica. |
JP2015527630A (ja) | 2012-06-06 | 2015-09-17 | ザ プロクター アンド ギャンブルカンパニー | ヘア/頭皮ケア組成物向け化粧剤の同定システム及び方法 |
FR3116273B1 (fr) * | 2020-11-17 | 2023-10-27 | Sederma Sa | Tétrapeptides, compositions les comprenant et leur utilisation cosmétique |
KR102484277B1 (ko) * | 2021-11-22 | 2023-01-04 | 대한켐텍 주식회사 | 피부 미용 개선용 원료 조성물의 제조방법 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4877805A (en) * | 1985-07-26 | 1989-10-31 | Kligman Albert M | Methods for treatment of sundamaged human skin with retinoids |
DE19715103A1 (de) * | 1997-04-11 | 1998-10-15 | Targor Gmbh | Metallocen-Aminosäure- und Peptid-Komplexe |
WO1998047921A1 (en) * | 1997-04-21 | 1998-10-29 | Schering Corporation | Mammalian cytokines; related reagents and methods |
US6069129A (en) * | 1998-03-13 | 2000-05-30 | Mrs, Llc | Elastin derived composition and method of using same |
EP1054677B1 (en) * | 1998-11-19 | 2008-10-22 | Connective Tissue Imagineering LLC | Cosmetic or dermatological use of 7-hydroxylated steroids alone and/or in combination with elastin derived peptides |
AU784203B2 (en) * | 1999-10-29 | 2006-02-23 | Glaxosmithkline Biologicals S.A. | Neisserial antigenic peptides |
-
2001
- 2001-05-30 AU AU2001275018A patent/AU2001275018B2/en not_active Ceased
- 2001-05-30 WO PCT/US2001/017384 patent/WO2001091700A2/en active IP Right Grant
- 2001-05-30 EP EP01941684A patent/EP1392346A4/en not_active Ceased
- 2001-05-30 IL IL15368701A patent/IL153687A0/xx unknown
- 2001-05-30 AU AU7501801A patent/AU7501801A/xx active Pending
- 2001-05-30 CA CA002415225A patent/CA2415225A1/en not_active Abandoned
- 2001-05-30 NZ NZ523403A patent/NZ523403A/en active Application Filing
-
2003
- 2003-01-29 NO NO20030454A patent/NO20030454L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NZ523403A (en) | 2005-04-29 |
WO2001091700A2 (en) | 2001-12-06 |
EP1392346A4 (en) | 2006-10-25 |
AU2001275018B2 (en) | 2008-04-03 |
NO20030454D0 (no) | 2003-01-29 |
NO20030454L (no) | 2003-01-29 |
CA2415225A1 (en) | 2001-12-06 |
EP1392346A2 (en) | 2004-03-03 |
WO2001091700A8 (en) | 2003-11-20 |
AU7501801A (en) | 2001-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU8657601A (en) | Composition and method for treatment of hypertriglyceridemia | |
AU2002230831A1 (en) | Compositions of human proteins and method of use thereof | |
IL213845A0 (en) | Method and composition for treatment of skeletal dysplasias | |
AU1166502A (en) | Human ect2 and methods of use | |
EP1157707B8 (en) | Method and composition for deforming soft tissues | |
GB0014969D0 (en) | Novel method of treatment | |
EP1438062A4 (en) | METHOD AND COMPOSITIONS FOR TREATING SKIN Lions | |
GB0110288D0 (en) | Composition and treatment method | |
AU6832101A (en) | Composition and method | |
AU4163402A (en) | Composition and method | |
AU7501801A (en) | Composition and method for enhancing elasticity of tissue | |
HK1047879A1 (zh) | 改進的假肢及其裝配方法 | |
AU7311501A (en) | Cosmetic composition and method | |
HU0104832D0 (en) | Cosmetic composition and method | |
AU2001234831A1 (en) | Magnetoliposome composition for targeted treatment of biological tissue and associated methods | |
AU2003282593A8 (en) | Polyphenolamine composition and method of use | |
EP1263935A4 (en) | SCYTONEMINE AND METHODS OF USE | |
GB2399500B (en) | Composition and method for treatment of wounds | |
GB0008921D0 (en) | Method of treatment | |
IL151403A0 (en) | Compositions and methods for treatment of epilepsy | |
GB0105472D0 (en) | Smoke composition and method of use thereof | |
AU2001253469A1 (en) | Compositions and methods for stabilizing modified tissue | |
EP1272512A4 (en) | IMMUNOKIN COMPOSITION AND METHOD | |
EP1303281A4 (en) | METHODS OF TREATMENT | |
GB0016437D0 (en) | Method of and composition for tattooing |